2. Peptides
  3. Peptide and Derivatives
  4. Others
 

Others (663):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P1902
    Cardiotoxin Analog (CTX) IV (6-12) 115722-23-1 99.20%
    Cardiotoxin Analog (CTX) IV (6-12) is a part peptide of Cardiotoxin Analog (CTX) IV. Cardiotoxin analogues IV isolated from the venom of Taiwan Cobra. CTX IV is an unique snake venom cardiotoxin.
    Cardiotoxin Analog (CTX) IV (6-12)
  • HY-P1860
    TNF-α (31-45), human 144796-71-4 99.77%
    TNF-α (31-45), human is a potent NF-kB pathway activator. TNF-αis a proinflammatory cytokine that induces necrosis or apoptosis. TNF alpha stimulates NF-κB pathway via TNFR2 promotes cancer growth, invasion, and metastasis.
    TNF-α (31-45), human
  • HY-P1902A
    Cardiotoxin Analog (CTX) IV (6-12) (TFA) 2918768-05-3 99.53%
    Cardiotoxin Analog (CTX) IV (6-12) (TFA) is a part peptide of Cardiotoxin Analog (CTX) IV. Cardiotoxin analogues IV isolated from the venom of Taiwan Cobra. CTX IV is an unique snake venom cardiotoxin.
    Cardiotoxin Analog (CTX) IV (6-12) (TFA)
  • HY-P1568A
    Flagelin 22 TFA
    Flagelin 22 TFA (Flagellin 22 TFA), a fragment of bacterial flagellin, is an effective elicitor in both plants and algae.
    Flagelin 22 TFA
  • HY-P2048A
    MOTS-c(human) acetate 98.97%
    MOTS-c(human) acetate is a mitochondrial-derived peptide. MOTS-c(human) acetate induces the accumulation of AMP analog AICAR, increases activation of AMPK and expression of its downstream GLUT4. MOTS-c(human) acetate induces glucose uptake and improves insulin sensitivity. MOTS-c(human) acetate has implications in the regulation of obesity, diabetes, exercise, and longevity.
    MOTS-c(human) acetate
  • HY-P4371A
    Hel 13-5 TFA 98.22%
    Hel 13-5 TFA is a monomeric synthetic peptide based on the N-terminal fragment of human SP-B. Hel 13-5 TFA is mainly α-helical and consists of 13 hydrophobic amino acid residues and 5 hydrophilic amino acid residues. Hel 13-5 TFA can be combined with phospholipids for the development of a model system for pulmonary surfactant.
    Hel 13-5 TFA
  • HY-W756654
    Homoglutathione TFA
    Homoglutathione (TFA) is a biological molecule.
    Homoglutathione TFA
  • HY-P5028A
    Cyclo(His-Phe) TFA 147600-13-3 99.94%
    Cyclo(His-Phe) TFA is aCyclic dipeptide.
    Cyclo(His-Phe) TFA
  • HY-P4632
    H-γ-Glu-Leu-OH 2566-39-4 99.67%
    H-γ-Glu-Leu-OH is a dipeptide consisting of γ-glutamic acid and leucine, terminated by a hydroxyl group.
    H-γ-Glu-Leu-OH
  • HY-P2528
    Enhanced Green Fluorescent Protein (EGFP) (200-208) 323198-39-6 98.91%
    Enhanced Green Fluorescent Protein (EGFP) (200-208) is a marker gene product derived from the jellyfish Aequorea Victoria. Enhanced Green Fluorescent Protein (EGFP) (200-208) is a common reporter protein and is easy to detect.
    Enhanced Green Fluorescent Protein (EGFP) (200-208)
  • HY-D0889
    Glycylglycine 556-50-3 99.90%
    Glycylglycine is the simplest of all peptides and could function as a gamma-glutamyl acceptor.
    Glycylglycine
  • HY-P1851A
    AGA-(C8R) HNG17, humanin derivative TFA 98.34%
    AGA-(C8R) HNG17, humanin derivative TFA is a potent humanin (HN) derivative. AGA-(C8R) HNG17, humanin derivative completely suppresses neuronal cell death by Alzheimer's disease-relevant insults.
    AGA-(C8R) HNG17, humanin derivative TFA
  • HY-P3993A
    (Gly14)-Humanin (human) (acetate) 99.86%
    (Gly14)-Humanin (human) (14-Glycine-Humanin (human)) acetate is an analog of Humanin in which the 14th amino acid serine was replaced with glycine (Gly). (Gly14)-Humanin (human) acetate has anti-apoptotic and neuroprotective functions.
    (Gly14)-Humanin (human) (acetate)
  • HY-101399
    γ-Glu-Phe 7432-24-8 99.82%
    γ-Glu-Phe (γ-Glutamylphenylalanine) is synthesized by Bacillus amyloliquefaciens (GBA) and Aspergillus oryzae (GAO). γ-Glu-Phe or the post-enzymatic reaction mixture enhances the umami intensity of commercial soy sauce and model chicken broth.
    γ-Glu-Phe
  • HY-112173
    Prolylleucine 61596-47-2 99.85%
    Prolylleucine is a dipeptide containing branched-chain amino acids. Prolylleucine can affect the circadian rhythms and behaviour of animals.
    Prolylleucine
  • HY-P1939
    Cyclo(L-Leu-L-Pro) 2873-36-1 99.84%
    Cyclo(L-Leu-L-Pro) is an inhibitory substance targeting to production of norsolorinic acid (NA，a precursor of aflatoxin)，which can be isolated from A. xylosoxidans NFRI-A1. Cyclo(L-Leu-L-Pro) inhibits accumulation of NA by A. parasiticus NFRI-95 and inhibits spore formation. Cyclo(L-Leu-L-Pro) inhibits aflatoxin production with an IC50 of 0.2 mg/mL in A. parasiticus SYS-4.
    Cyclo(L-Leu-L-Pro)
  • HY-P1027
    LEP(116-130)(mouse) 258276-95-8 98.13%
    LEP(116-130)(mouse) is a synthetic leptin peptide fragment.
    LEP(116-130)(mouse)
  • HY-W092109
    H-Phe-Trp-OH 24587-41-5 99.22%
    H-Phe-Trp-OH (Phenylalanyltryptophan) is an endogenous metabolite.
    H-Phe-Trp-OH
  • HY-W015450
    D-Ala-D-Ala 923-16-0
    D-Ala-D-Ala constitutes the terminus of the peptide part of the peptidoglycan monomer unit and is involved in the transpeptidation reaction as the substrate. D-Ala-D-Ala is catalyzed by D-Alanine-D-Alanine ligase. D-Ala-D-Ala is a bacterial endogenous metabolite.
    D-Ala-D-Ala
  • HY-P4909
    Autoinducing Peptide I 200010-29-3 99.27%
    Autoinducing Peptide I is a cyclic octapeptide secreted by Staphylococcus aureus and can be used in vaccine research.
    Autoinducing Peptide I